| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |